The Beauty Health Company

NASDAQ:SKIN

Household & Personal Products

Consumer Defensive
$12.46 +6.17%

+$0.04 today

Market cap
$81.18M
Beta
1.07
P/E (TTM)
-14.6
EPS (TTM)
-$0.05
52W Low $0.55High $2.69

Volume 0.05M

Average 0.95M

SKIN Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

The Beauty Health CompanyNASDAQ: SKIN

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation declines year over year

Q1 FY2026 stock-based compensation of $2.08M fell 40.2% year over year, ahead of the -43.0% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 42.0% from the prior quarter. Over 3 fiscal years it compounded at -19.6% a year.

Context

  • Stock-based compensation amounted to 4.9% of revenue in FY2025, down 3.1 pp from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -40.2% holds above the trailing-twelve-month pace of -43.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.08M-42.0% QoQ
Last fiscal yearDec 2025
$14.82M-44.5% YoY
LTMMar 2026
$13.43M-43.0% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-40.2%——
1 year-44.5%——
3-year CAGR-19.6%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
14.82M USD
Year-over-year change
-44.5%
4-year CAGR
+4.5%

Stock-Based Compensation vs competitors

How SKIN compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -43.0% is the lowest of 6, against a peer median of -27.9%.
  • Stock-based compensation amounts to 4.5% of revenue for SKIN, versus a peer median of 1.3%.
SKIN Competitors
Stock-Based Compensation for SKIN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACUAcme United CorporationLTM Mar 2026$1.99B USD+92814.8%+934.0%983.3%
SKINThe Beauty Health CompanyLTM Mar 2026$13.43M USD-43.0%-19.6%4.5%
SKILSkillsoft Corp.LTM Apr 2026$12M USD-27.3%-28.8%2.5%
ZVIAZevia PBCLTM Mar 2026$3.03M USD-27.9%—1.8%
SLSNSolesence, Inc. Common StockLTM Mar 2026$448K USD-35.3%-2.7%0.7%
FTLFFitLife Brands, Inc.LTM Mar 2026$314K USD-32.3%+3.6%0.3%
YOULYoulife Group Inc.FY2025CN¥0 CNY——0.0%
Peer median (excluding SKIN) —-27.9%+0.4%1.3%

Competitors are the stored peer set for SKIN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(375.11M)44.38M(100.12M)(29.1M)(9.5M)
Depreciation & Amortization21.14M22.02M34.68M33.68M25.35M
Deferred Income Tax(3.76M)(1.79M)(1.08M)(3.75M)2.22M
Stock-Based Compensation12.42M28.5M22.54M26.7M14.82M
Change in Working Capital(18.66M)(140.28M)23.36M(27.39M)10.37M
Accounts Receivables(31.01M)(32.03M)12.85M20.8M8.59M
Inventory(9.44M)(82.1M)19.57M(10.5M)15.8M
Accounts Payables10.52M1.61M15.78M(43.78M)(7.2M)
Other Working Capital11.27M(27.77M)(24.85M)6.08M(6.83M)
Other Non-Cash Items335.62M(59.43M)41.29M16M36.63M
Operating Cash Flow(28.36M)(106.6M)21.75M16.13M37.5M
Capital Expenditures(15.62M)(17.39M)(13.05M)(6.79M)(303K)
Acquisitions (Net)(22.9M)(1.48M)(18.46M)00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities781K0000
Investing Cash Flow(37.73M)(18.87M)(31.51M)(6.79M)(5.16M)
Debt Repayment524.51M00(156.08M)(173.35M)
Common Stock Issued938.38M000(1.57M)
Common Stock Repurchased0(160M)(32.4M)(1.96M)0
Dividends Paid00000
Other Financing Activities(503.86M)(45.24M)(1.82M)(302K)26K
Financing Cash Flow959.04M(205.24M)(37.45M)(158.34M)(174.9M)
Effect of Forex Changes(543K)(2.98M)2.03M(3.96M)5.21M
Net Change in Cash892.4M(333.69M)(45.17M)(152.96M)(137.4M)
Free Cash Flow(43.98M)(123.99M)8.7M9.34M37.18M

The Beauty Health Company

NASDAQ:SKIN

Intrinsic Alpha fair value

Locked

Current Price

$12.46

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.